1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-383

PAR-25-383National Institutes of HealthUG3

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Jun 17, 2025

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to pursue translational activities and clinical studies to advance the development of medical devices to prevent, monitor, diagnose, and treat disorders within the missions of the participating NIH institutes and centers, as well as the NIH Brain…

Related NIH announcements2

Other open UG3 announcements on related subjects, with at least two weeks to go.

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

PAR-25-446National Institutes of Health3 review criteria on fileagency framework

$3M

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

RFA-NS-27-007National Institutes of Health3 review criteria on file

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Neuroscience, Substance use), with at least two weeks to apply.

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

PAS-27-028National Institutes of Health3 review criteria on fileagency framework

—

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

RFA-AG-27-010National Institutes of Health

—

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

PAR-24-089National Institutes of Health5 review criteria on fileagency framework

$750k

Everything open tagged Neuroscience

Hiring in this research area now

All neuroscience jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-383.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.